Get started
Author

Fiorenza Irushani Vanderwert

Observed names: F.I. Vanderwert, Fiorenza I. Vanderwert, Fiorenza Irushani, Fiorenza Vanderwert, Vanderwert, Fiorenza
OpenAlex ID: A5070823712
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis
2022 · Benedetta Sordi, Fiorenza Vanderwert, et al. · Journal of Allergy and Clinical Immunology · 51
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
2023 · Laura Calabresi, Chiara Carretta, et al. · American Journal of Hematology · 17
PDF
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
2024 · Ilaria Tanasi, Lara Crosera, et al. · Bone · 12
Diagnostic and therapeutic challenges in mast cell sarcoma
2022 · Francesco Mannelli, Francesca Gesullo, et al. · American Journal of Hematology · 6
PDF
Revised International Working Group Risk Model for Survival in Polycythemia Vera
2024 · Ayalew Tefferi, Giuseppe Gaetano Gaetano Loscocco, et al. · Blood · 3
Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML
2025 · Francesco Mannelli, Matteo Piccini, et al. · Blood Cancer Journal · 2
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management
2022 · Francesca Crupi, Benedetta Sordi, et al. · International Journal of Molecular Sciences · 2
PDF
Screening for Hereditary Alpha-Tryptasemia in Subjects with Systemic Mastocytosis (SM) and Non-SM Mast Cell Activation Symptoms
2021 · Fiorenza Irushani Vanderwert, Benedetta Sordi, et al. · Blood · 2
Mutation Landscape and Prognostic Correlates of ASXL1 Variants in Primary and Secondary Myelofibrosis
2021 · Giacomo Coltro, Paola Guglielmelli, et al. · Blood · 1
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia
2026 · Niccolò Bartalucci, Francesco Mannelli, et al. · Blood Cancer Journal
PDF
Mutational architecture and clonal heterogeneity in myelofibrosis: Prognostic role of variant type and acquisition sequence
2025 · Fiorenza Vanderwert, Valentina Boldrini, et al. · Blood
PDF
Clonal architecture inferred from routine NGS data predicts outcome and response to JAK-inhibitors in myelofibrosis
2025 · Valentina Boldrini, Alessio Enderti, et al. · Blood
PDF
Identification of Genomic Structural Variants (SVs) with Adverse Prognostic Significance in Normal-Karyotype (nk) Acute Myeloid Leukemia (AML) Patients
2024 · Niccolò Bartalucci, Francesco Mannelli, et al. · Blood
PDF
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting
2024 · Gaia Ciolli, Matteo Piccini, et al. · Haematologica
PDF
Selected Genomic Structural Variants Refine ELN-Based Prognostic Stratification of Patients with Acute Myeloid Leukemia and Normal Karyotype
2023 · Niccolò Bartalucci, Francesco Mannelli, et al. · Blood
PDF
The Impact of Baseline Genetic Profile and Treatment on Hematological Toxicity in CEBPA-Mutated Acute Myeloid Leukemia
2023 · Francesco Mannelli, Matteo Piccini, et al. · Blood
PDF
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis
2022 · Paola Guglielmelli, Fiorenza Irushani Vanderwert, et al. · Blood
Sequencing Approach to Identify Candidate Genes Involved in Short Stature
2019 · Daniela Formicola, Angelica Pagliazzi, et al. · 58th Annual ESPE Meeting (ESPE 2019)
Works count: 20
Citation count: 95
H-index: 4
I10-index: 3
Year
Topic
Type